MAP3K14 and acute myeloid leukemia: Two hairpins targeting mitogen activated protein kinase 14 (MAPK14 or p38α) fulfilled these criteria, suggesting that p38α loss sensitizes AML cells to PIM inhibition (Figure 1D).